Radionecrosis after stereotactic radiotherapy for brain metastases (Q31095955)

28 June 2017

1 reference

title

Radionecrosis after stereotactic radiotherapy for brain metastases (English)

1 reference

28 June 2017

1 reference

G Vogin

3

0 references

author name string

E Le Rhun

1

1 reference

28 June 2017

F Dhermain

2

1 reference

28 June 2017

N Reyns

4

1 reference

28 June 2017

P Metellus

5

1 reference

28 June 2017

publication date

13 May 2016

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

28 June 2017

published in

1 reference

28 June 2017

volume

16

1 reference

28 June 2017

issue

8

1 reference

28 June 2017

page(s)

903-914

1 reference

Management of brain metastases: surgery, radiation, or both?

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Stereotactic radiosurgery in the management of brain metastases: an institutional retrospective analysis of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-o

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Three-fraction CyberKnife radiotherapy for brain metastases in critical areas: referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Effect of bevacizumab on radiation necrosis of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Repeated stereotactic radiosurgery for patients with progressive brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Neurotoxicity of radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

MR spectroscopy in radiation injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Pathological review of late cerebral radionecrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Acute hemorrhage in late radiation necrosis of the temporal lobe: report of five cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Neurologic complications of radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Upregulation of VEGF and FGF2 in normal rat brain after experimental intraoperative radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Treatment outcomes using CyberKnife for brain metastases from lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Risk analysis of linear accelerator radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Radiosurgery to the postoperative surgical cavity: who needs evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

An analysis of radiation necrosis of the central nervous system treated with bevacizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Linear accelerator stereotactic radiosurgery for metastatic brain tumors: 17 years of experience at the University of Florida

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Reoperation for recurrent metastatic brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Operative intervention for delayed symptomatic radionecrotic masses developing following stereotactic radiosurgery for cerebral arteriovenous malformations--case analysis and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Radiation-induced brain injury: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Local control after fractionated stereotactic radiation therapy for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

The results of resection after stereotactic radiosurgery for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Managing the cognitive effects of brain tumor radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Challenges with the diagnosis and treatment of cerebral radiation necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Treatment of steroid refractory, Gamma Knife related radiation necrosis with bevacizumab: Case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Radionecrosis of malignant glioma and cerebral metastasis: a diagnostic challenge in MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Diagnostic Accuracy of PET, SPECT, and Arterial Spin-Labeling in Differentiating Tumor Recurrence from Necrosis in Cerebral Metastasis after Stereotactic Radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1-3 cerebral metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Radiation dose-volume effects in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Surgical treatment of brain metastasis: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Resection of brain metastases previously treated with stereotactic radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Hyperbaric oxygen therapy for radiation-induced brain injury in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Bevacizumab used for the treatment of severe, refractory perilesional edema due to an arteriovenous malformation treated with stereotactic radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Bevacizumab as a treatment option for radiation-induced cerebral necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

Bevacizumab reverses cerebral radiation necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14737175.2016.1184572

10.1080/14737175.2016.1184572

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference